Tag Archives: ASND

Top 10 Medical Stocks For 2022

Among stocks seeing big moves in after-hours trading Thursday, AbCellera Biologics  (ABCL)  gained after saying it won emergency use authorization from the Food and Drug Administration for a treatment of people who’ve been exposed to COVID. The company said its bamlanivimab drug can now be used in combination with another drug called etesevimab “to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination.”

The move “provides a way to protect the significant number of people who, because of their situational exposure risk or medical condition, remain vulnerable to COVID-19,” said Carl Hansen, CEO and president of AbCellera, in a statement.

Top 10 Medical Stocks For 2022: GWG Holdings, Inc(GWGH)

GWG Holdings, Inc., incorporated on March 19, 2008, is a specialty finance company. The Company is a financial purchaser of life insurance assets in the secondary market. The Company creates opportunities for consumers owning life insurance to obtain value for their policies as compared to the traditional options offered by insurance companies. The Company also creates opportunities for investors to participate in alternative asset classes, such as life insurance, not correlated to traditional financial markets. The Company conducts its life insurance related business through a subsidiary, GWG Life, LLC (GWG Life), and GWG Life’s subsidiaries, GWG Trust (Trust), GWG DLP Funding II, LLC (DLP II) and GWG DLP Funding III, LLC (DLP III).

The Company generally purchases life insurance assets directly from policy owners having purchased their life insurance in the primary market. The Company focuses on purchasing life insurance assets through its origination practices and underwriting procedures. The Company obtains life expectancies from independent third-party medical-actuarial underwriting firms. The Company’s operational platform offers various options to customers based on the market value of their life insurance, including selling the entire policy benefit for cash, or selling a portion of the policy benefit and retaining a portion of the benefit with no future premium obligation.

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    ValuEngine cut shares of GWG (NASDAQ:GWGH) from a sell rating to a strong sell rating in a report issued on Friday morning.

    Several other equities analysts have also issued reports on GWGH. Zacks Investment Research lowered GWG from a strong-buy rating to a hold rating in a research note on Tuesday, July 17th. Maxim Group reissued a buy rating and issued a $14.00 price target on shares of GWG in a research note on Thursday, August 16th.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Here are some of the news articles that may have effected Accern Sentiment’s analysis:

    Get GWG alerts:

    Critical Review: Citizens (CIA) vs. GWG (GWGH) (americanbankingnews.com) (Watch) Zibanejad scores in Sweden’s win over Russia (sny.tv) GWG Holdings’ (GWGH) CEO Jon Sabes on Q1 2018 Results – Earnings Call Transcript (msn.com) Edited Transcript of GWGH earnings conference call or presentation 14-May-18 8:30pm GMT (finance.yahoo.com) DWWA judge profile: Davide Buongiorno (decanter.com)

    A number of equities research analysts recently commented on the company. Zacks Investment Research raised GWG from a “hold” rating to a “buy” rating and set a $9.25 price target for the company in a research report on Wednesday, April 11th. ValuEngine lowered GWG from a “hold” rating to a “sell” rating in a research report on Monday, May 14th. Finally, Maxim Group reaffirmed a “buy” rating and set a $14.00 target price on shares of GWG in a research report on Tuesday, January 23rd.

Top 10 Medical Stocks For 2022: Ascendis Pharma A/S(ASND)

Ascendis Pharma A/S, incorporated on October 21, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop a pipeline of long-acting prodrug therapies that address markets with unmet medical needs. The Company is developing its product candidate, TransCon human growth hormone (TransCon hGH) for once-weekly administration to treat growth hormone deficiency (GHD) and other indications. In addition to TransCon hGH, the Company has developed a pipeline of long-acting prodrug product candidates, such as TransCon Treprostinil for the treatment of pulmonary arterial hypertension (PAH), TransCon Peptides for the treatment of diabetes and TransCon Ranibizumab for the treatment of ophthalmology. The Company’s subsidiaries include Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma, Osteoarthritis Division A/S (Denmark) and Ascendis Pharma, and Circulatory Diseases Division A/S (Denmark).

TransCon human Growth Hormone

The Company is developing TransCon hGH as a prodrug with once-weekly administration that releases unmodified growth hormone, maintaining the same mode of action as daily hGH therapies. Clinical studies of TransCon hGH have demonstrated a comparable immunogenic profile to that of daily growth hormone. The Company has completed a Phase II study of TransCon hGH in adults with GHD and is conducting a six-month Phase II study in children with GHD. In the Phase II study, the Company is measuring height velocity, an efficacy measure that refers to the mean height change of the individuals in a group over a specified time period. In addition, the Company is developing a pen device with Bang & Olufsen Medicom A/S for administration of TransCon hGH that is designed for the pediatric population.

TransCon Treprostinil

The Company is developing! TransCon Treprostinil as a once-daily self-administered subcutaneous injection of treprostinil for the treatment of PAH, a disease characterized by elevated blood pressure in the pulmonary arteries. The Company is applying its TransCon technology to develop TransCon Treprostinil to be given as a once-daily injection rather than as continuously infused therapy. The Company initiated a Phase I clinical proof-of-concept study of TransCon Treprostinil.

TransCon Peptide

TransCon Peptide is indicated for the treatment of diabetes. The Company is conducting preclinical studies to evaluate the various TransCon prodrug candidates for the treatment of diabetes.

TransCon Ranibizumab

The Company along with its collaboration partner, Genentech, is developing TransCon Ranibizumab, for treatment of ophthalmic diseases. TransCon Ranibizumab is a compound designed to support up to half-yearly injection of ranibizumab, the active agent in Genentech’s Lucentis (ranibizumab injection). Lucentis belongs to a class of drug therapies known as anti-vascular endothelial growth factor (anti-VEGF) treatments, which require periodic intravitreal injections. Lucentis is indicated for neovascular wet age-related macular degeneration, macular edema following retinal vein occlusion and diabetic macular edema.

The Company competes with Bioton S.A., Critical Pharmaceuticals, Ltd., Dong-A Pharmaceutical, GeneScience Pharmaceuticals Co., Ltd., Genexine Inc., Hanmi Pharmaceuticals Co., Ltd., Novo Nordisk A/S, OPKO Health, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Versartis, Inc.

Advisors’ Opinion:

  • [By Jim Halley (TMFjimhalley)]

    Shares of Ascendis Pharma (NASDAQ:ASND) climbed more than 25% this week, almost all of that on Thursday. The stock opened at $120.71 on Monday and it wasn’t until Wednesday that it began to climb, rising to $123.67 at the close and shortly before it announced news from the Food and Drug Administration (FDA). On Thursday, Ascendis opened at $150.57 and rose as high as $158.78 during the day before closing at $149.70, still a jump of more than $26 from the day before.

  • [By Motley Fool Transcribers]

    Ascendis Pharma A/S (NASDAQ:ASND)Q42018 Earnings Conference CallApril 03, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks For 2022: Tortoise MLP Fund, Inc.(NTG)

Tortoise MLP Fund, Inc. is a non-diversified, closed-end management investment fund. The Fund’s primary investment objective is to seek a high level of total return with an emphasis on current distributions. It invests primarily in master limited partnerships (MLPs) and their affiliates that own and operate a network of pipeline and energy-related logistical infrastructure assets. Under normal circumstances, it invests approximately 80% of its total assets (including assets obtained through leverage) in equity securities of MLPs in energy infrastructure sector, with approximately 50% of its total assets in equity securities of natural gas infrastructure MLPs. The Fund may also invest approximately 50% of its total assets in restricted securities. Its portfolio includes in natural gas/natural gas liquids pipelines, gathering and processing, crude oil pipelines, refined product pipelines, and oil and gas production. Tortoise Capital Advisors, L.L.C. is the investment adviser to the Fund. Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Northgate plc (LON:NTG) have received an average rating of “Buy” from the six brokerages that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is GBX 523.25 ($6.67).

Top 10 Medical Stocks For 2022: Sempra Energy(SRE)

We provide a description of Sempra Energy and its subsidiaries in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and additional information by reporting segment in Note 16 of the Notes to Consolidated Financial Statements, both in the 2015 Annual Report to Shareholders (Annual Report), which is attached as Exhibit 13.1 to this report and is incorporated herein by reference. This report includes information for the following separate registrants: Sempra Energy and its consolidated entities
San Diego Gas & Electric Company (SDG&E)
Southern California Gas Company (SoCalGas)
References in this report to “we,” “our,” “us,” “our company” and “Sempra Energy Consolidated” are to Sempra Energy and its consolidated entities, collectively, unless otherwise indicated by the context. SDG&E and SoCalGas are collectively referred to as the California Utilities.   Advisors’ Opinion:

  • [By Lee Jackson]

    This is another solid defensive play. Sempra Energy (NYSE: SRE) is a natural gas transmission and distribution company headquartered in San Diego. Company operations are divided into three segments. The California Utilities segment (South California Gas and San Diego Gas and Electric) distributes gas and electricity to approximately 25 million customers in Southern California. The other segments are Sempra US Gas & Power and Sempra International.

  • [By Maxx Chatsko]

    That said, the insatiable global demand for LNG, especially from energy-poor Asian countries desperately looking to transition away from dirtier coal-fired power plants and industry, means there’s plenty of LNG riches to go around. Dominion Energy and Kinder Morgan are likely to remain relatively small players in the industry, but players nonetheless. Sempra Energy (NYSE:SRE) figures to be a more prominent supplier of the energy source with its Cameron LNG terminal, while privately held Freeport LNG is the majority owner of a project bearing the same name.

Top 10 Medical Stocks For 2022: Mind Medicine(MNMD)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Thomas Niel]

    It’s likely won’t be until 2022 that Clovis Oncology stock takes off again. For now, shares could continue to tread water between $4 and $5 per share. But if you’re looking for a biotech penny stock with potential to gain big on FDA news, this may be one of your best options.

    Penny Stocks to Watch: Mind Medicine (MNMD)

  • [By ]

    Mind Medicine  (MNMD) : “I'm a believer that this is a great speculative stock, but remember, stocks can go to zero.”

    Affirm Holdings  (AFRM) – Get Report: “I like Affirm and I'm a buyer.”

  • [By ]

    If GSAT’s profitability sees big growth moving forward, its valuation could go up as well. Of course, as Navellier put it, this may take time. But with the risk-return proposition in your favor, speculating on this one of the penny stocks could be a wise move.

    Penny Stocks to Buy: Mind Medicine (MNMD) Source: Shutterstock

    Next up on this list of penny stocks is Mind Medicine. First off, there’s no denying MNMD stock belongs in the “moonshot” category of investment opportunities. In case you don’t know, this early stage company focuses on turning psychedelics (such as LSD) into treatments for conditions like anxiety disorders.

Top 10 Medical Stocks For 2022: Sterling Construction Company Inc(STRL)

Sterling Construction Company, Inc., incorporated on April 1, 1991, is a heavy civil construction company engaged in the building and reconstruction of transportation and water infrastructure projects in Texas, Utah, Nevada, Arizona, California, Hawaii and other states. The Company’s transportation infrastructure projects include highways, roads, bridges, airfields, ports and light rail. Its water infrastructure projects include water, wastewater and storm drainage systems. The Company operates through heavy civil construction segment. The Company provides its services by using traditional general contracting arrangements, such as lump sum contracts and cost-plus contracts.

The Company serves various markets in the United States, including Texas, Utah, Nevada, Arizona, California and Hawaii. The Company’s customers include departments of transportation in various states (DOTs), regional transit authorities, airport authorities, port authorities, water authorities and railroads. The Company owns interest in subsidiaries, which include Texas Sterling Construction Co. (TSC); Road and Highway Builders, LLC (RHB); Road and Highway Builders Inc. (RHB Inc); Road and Highway Builders of California, Inc. (RHBCa); RHB Properties, LLC (RHBP); Ralph L. Wadsworth Construction Company, LLC (RLW); Ralph L. Wadsworth Construction Co., LP (RLWLP); J. Banicki Construction, Inc.(JBC); Myers & Sons Construction, L.P. (Myers), and Sterling Hawaii Asphalt (SHA).

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Sterling Construction Inc (NASDAQ:STRL)Q42018 Earnings Conference CallMarch 05, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Sterling Construction Company Inc (NASDAQ:STRL) – Equities research analysts at DA Davidson lowered their Q3 2018 earnings per share estimates for Sterling Construction in a research note issued to investors on Tuesday, May 8th. DA Davidson analyst B. Thielman now anticipates that the construction company will earn $0.37 per share for the quarter, down from their prior forecast of $0.38. DA Davidson also issued estimates for Sterling Construction’s Q4 2018 earnings at $0.21 EPS.

Top 10 Medical Stocks For 2022: Unit Corporation(UNT)

Unit Corporation, together with its subsidiaries, engages in the contract drilling, oil and natural gas, and mid-stream businesses in the United States. The company?s Contract Drilling segment engages in land contract drilling of onshore oil and natural gas wells for oil and natural gas companies in Oklahoma, Texas, Louisiana, Wyoming, Colorado, Utah, Montana, and North Dakota. Its Oil and Natural Gas segment is involved in the acquisition, exploration, development, and production of oil and natural gas properties located primarily in Oklahoma, Texas, Louisiana, and North Dakota, as well as in Arkansas, New Mexico, Wyoming, Montana, Alabama, Kansas, Mississippi, Michigan, Colorado, Pennsylvania, and a small portion in Canada. As of December 31, 2011, this segment had approximately 121 gross proved undeveloped wells. The company?s Mid-Stream segment buys, sells, gathers, processes, and treats natural gas. It operates 3 natural gas treatment plants, 10 operating processing plants, 35 active gathering systems, and 934 miles of pipeline in Oklahoma, Texas, Kansas, Pennsylvania, and West Virginia. The company operates a fleet of 127 drilling rigs. Unit Corporation was founded in 1963 and is based in Tulsa, Oklahoma.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Unit Corp (NYSE:UNT)Q42018 Earnings Conference CallFeb. 21, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Shares of Unit Co. (NYSE:UNT) were down 7.6% on Monday . The company traded as low as $24.77 and last traded at $24.94. Approximately 597,400 shares changed hands during mid-day trading, an increase of 36% from the average daily volume of 439,071 shares. The stock had previously closed at $26.98.

  • [By Max Byerly]

    Unit Co. (NYSE:UNT) shares hit a new 52-week high on Friday . The company traded as high as $29.06 and last traded at $27.33, with a volume of 16258 shares trading hands. The stock had previously closed at $27.39.

  • [By Logan Wallace]

    SG Americas Securities LLC boosted its position in shares of Unit Co. (NYSE:UNT) by 284.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,374 shares of the oil and gas company’s stock after buying an additional 15,809 shares during the quarter. SG Americas Securities LLC’s holdings in Unit were worth $546,000 as of its most recent SEC filing.

Top 10 Medical Stocks For 2022: IEC Electronics Corp.(IEC)

IEC Electronics Corp., together with its subsidiaries, provides electronic contract manufacturing services in the United States. It specializes in the custom manufacture of circuit boards and system-level assemblies; various cable and wire harness assemblies; and precision metal components. The company offers its assemblies for use in various products, such as aerospace and defense systems, medical devices, industrial equipment, and transportation products. It serves aerospace and defense, medical, industrial, communications, and other sectors through a direct sales force, as well as through a network of manufacturers representatives. The company was founded in 1966 and is headquartered in Newark, New York.

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)

Top 10 Medical Stocks For 2022: Newcastle Investment Corporation(NCT)

Newcastle Investment Corp. (Newcastle), incorporated on June 6, 2002, is a real estate investment trust (REIT). The Company focuses on investing in, and managing, a range of real estate related and other investments. The Company’s segments include debt investments financed with collateralized debt obligations (CDOs), other debt investments (Other Debt), investment in golf properties and facilities (Golf) and corporate. The Company is externally managed and advised by an affiliate of Fortress Investment Group LLC (Fortress) (the Manager). The Company invests in real estate related debt and golf related real estate and operations. The Company’s investments are primarily secured by or related to commercial real estate.

The Company’s golf business includes approximately 90 properties in the United States that the Company leases, owns or manages. The Company’s investment portfolio includes debt investments, such as commercial assets, residential assets, corporate assets, and other investments, such as golf investment.

Advisors’ Opinion:

  • [By Ethan Ryder]

    PolySwarm (CURRENCY:NCT) traded 0.8% higher against the US dollar during the 24 hour period ending at 10:00 AM E.T. on September 16th. PolySwarm has a market capitalization of $5.74 million and $6,140.00 worth of PolySwarm was traded on exchanges in the last day. In the last week, PolySwarm has traded 4.2% higher against the US dollar. One PolySwarm token can currently be purchased for $0.0037 or 0.00000057 BTC on major cryptocurrency exchanges including HitBTC, IDEX, DDEX and TOPBTC.

  • [By Logan Wallace]

    PolySwarm (CURRENCY:NCT) traded 8.5% lower against the dollar during the 24-hour period ending at 13:00 PM ET on August 28th. PolySwarm has a market capitalization of $5.86 million and $7,097.00 worth of PolySwarm was traded on exchanges in the last day. One PolySwarm token can currently be purchased for approximately $0.0038 or 0.00000054 BTC on popular cryptocurrency exchanges including DDEX, TOPBTC, IDEX and HitBTC. In the last week, PolySwarm has traded 9.3% lower against the dollar.

  • [By Shane Hupp]

    PolySwarm (CURRENCY:NCT) traded 5.6% lower against the U.S. dollar during the 1-day period ending at 22:00 PM E.T. on July 4th. One PolySwarm token can now be purchased for $0.0039 or 0.00000059 BTC on major cryptocurrency exchanges including HitBTC, IDEX and DDEX. During the last seven days, PolySwarm has traded 8.4% higher against the U.S. dollar. PolySwarm has a total market cap of $5.94 million and $28,632.00 worth of PolySwarm was traded on exchanges in the last day.

Top 10 Medical Stocks For 2022: Eaton Vance Limited Duration Income Fund(EVV)

Eaton Vance Limited Duration Income Fund, is a diversified closed-end management investment company. The Fund’s investment objective is to provide a high level of current income. Its secondary objective is capital appreciation. The Fund invests primarily in mortgage-backed securities (MBS) issued, backed or otherwise guaranteed by the United States Government or its agencies or instrumentalities; senior, secured floating-rate loans made to corporate and other business entities (senior loans), and corporate bonds of below investment-grade quality (non-investment-grade bonds).

The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, leisure goods/activities/movies, business equipment and services, chemicals and plastics, cable and satellite television, conglomerates, containers and glass products, ecological services and equipment, non-ferrous metals/minerals, and oil and gas. Eaton Vance Management (EVM), a subsidiary of Eaton Vance Corp., acts as the Fund’s investment advisor and administrator. Investors Bank & Trust Company serves as the custodian of the Fund. The Fund may invest in Cash Management Portfolio an affiliated investment company managed by Boston Management and Research (BMR), a wholly owned subsidiary of EVM.

Advisors’ Opinion:

  • [By Logan Wallace]

    Eaton Vance Ltd Duration Income Fund (NYSEAMERICAN:EVV) was the recipient of a large increase in short interest in September. As of September 14th, there was short interest totalling 61,700 shares, an increase of 154.4% from the August 31st total of 24,249 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 199,358 shares, the short-interest ratio is currently 0.3 days.